Intestinal homeostasis and neoplasia studied using conditional transgenesis

References

• Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science247(4940), 322–324 (1990).
   PubMed Web of Science ®Google Scholar
• Su LK, Kinzler KW, Vogelstein B et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science256(5057), 668–670 (1992).
   PubMed Web of Science ®Google Scholar
• Shoemaker AR, Gould KA, Luongo C, Moser AR, Dove WF. Studies of neoplasia in the Min mouse. Biochim. Biophys. Acta1332(2), F25–F48 (1997).
   PubMed Web of Science ®Google Scholar
• Sansom OJ, Stark LA, Dunlop MG, Clarke AR. Suppression of intestinal and mammary neoplasia by lifetime administration of aspirin in Apc(Min/+) and Apc(Min/+), Msh2(-/-) mice. Cancer Res.61(19), 7060–7064 (2001).
   PubMed Web of Science ®Google Scholar
• Boolbol SK, Dannenberg AJ, Chadburn A et al. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res.56(11), 2556–2560 (1996).
   PubMed Web of Science ®Google Scholar
• Giardiello FM, Yang VW, Hylind LM et al. Primary chemoprevention of familial adenomatous polyposis with sulindac. N. Engl. J. Med.346(14), 1054–1059 (2002).
   PubMed Web of Science ®Google Scholar
• Clarke AR, Gledhill S, Hooper ML, Bird CC, Wyllie AH. p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following γ-irradiation. Oncogene9(6), 1767–1773 (1994).
   PubMed Web of Science ®Google Scholar
• Christophorou MA, Ringshausen I, Finch AJ, Swigart LB, Evan GI. The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature443(7108), 214–217 (2006).
   PubMed Web of Science ®Google Scholar
• Lewandoski M. Conditional control of gene expression in the mouse. Nat. Rev. Genet.2(10), 743–755 (2001).
   PubMed Web of Science ®Google Scholar
• Bullard DC, Weaver CT. Cutting-edge technology: IV. Genomic engineering for studies of the gastrointestinal tract in mice. Am. J. Physiol. Gastrointest. Liver Physiol.283(6), G1232–G1237 (2002).
   Google Scholar
• Garcia EL, Mills AA. Getting around lethality with inducible Cre-mediated excision. Semin. Cell Dev. Biol.13(2), 151–158 (2002).
   PubMed Web of Science ®Google Scholar
• Ryding AD, Sharp MG, Mullins JJ. Conditional transgenic technologies. J Endocrinol.171(1), 1–14 (2001).
   PubMed Web of Science ®Google Scholar
• Pinto D, Robine S, Jaisser F, El Marjou FE, Louvard D. Regulatory sequences of the mouse Villin gene that efficiently drive transgenic expression in immature and differentiated epithelial cells of small and large intestines. J. Biol. Chem.274(10), 6476–6482 (1999).
   PubMed Web of Science ®Google Scholar
• Schweinfest CW, Jorcyk CL, Fujiwara S, Papas TS. A heat-shock-inducible eukaryotic expression vector. Gene71(1), 207–210 (1988).
   PubMed Web of Science ®Google Scholar
• Hu MC, Davidson N. A combination of derepression of the lac operator-repressor system with positive induction by glucocorticoid and metal ions provides a high-evel-inducible gene expression system based on the human metallothionein-IIA promoter. Mol. Cell Biol.10(12), 6141–6151 (1990).
   PubMed Web of Science ®Google Scholar
• Abremski K, Hoess R. Bacteriophage P1 site-specific recombination. Purification and properties of the Cre recombinase protein. J. Biol. Chem.259(3), 1509–1514 (1984).
   PubMed Web of Science ®Google Scholar
• Hoess RH, Ziese M, Sternberg N. P1 site-specific recombination: nucleotide sequence of the recombining sites. Proc. Natl Acad. Sci. USA79(11), 3398–3402 (1982).
   PubMed Web of Science ®Google Scholar
• Sternberg N, Hamilton D. Bacteriophage P1 site-specific recombination. I. Recombination between loxP sites. J. Mol. Biol.150(4), 467–486 (1981).
   PubMed Web of Science ®Google Scholar
• Lakso M, Sauer B, Mosinger B Jr et al. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc. Natl Acad. Sci. USA89(14), 6232–6236 (1992).
   PubMed Web of Science ®Google Scholar
• Madison BB, Dunbar L, Qiao XT, Braunstein K, Braunstein E, Gumucio DL. Cis elements of the Villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. J. Biol. Chem.277(36), 33275–33283 (2002).
   PubMed Web of Science ®Google Scholar
• el Marjou F, Janssen KP, Chang BH et al. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis39(3), 186–193 (2004).
   Google Scholar
• Saam JR, Gordon JI. Inducible gene knockouts in the small intestinal and colonic epithelium. J. Biol. Chem.274(53), 38071–38082 (1999).
   PubMed Web of Science ®Google Scholar
• Kuhn R, Schwenk F, Aguet M, Rajewsky K. Inducible gene targeting in mice. Science269(5229), 1427–1429 (1995).
   PubMed Web of Science ®Google Scholar
• Ireland H, Kemp R, Houghton C et al. Inducible Cre-mediated control of gene expression in the murine gastrointestinal tract: effect of loss of β-catenin. Gastroenterology126(5), 1236–1246 (2004).
   PubMed Web of Science ®Google Scholar
• Campbell SJ, Carlotti F, Hall PA, Clark AJ, Wolf CR. Regulation of the CYP1A1 promoter in transgenic mice: an exquisitely sensitive on-off system for cell specific gene regulation. J. Cell Sci.109(Pt 11), 2619–2625 (1996).
   PubMed Web of Science ®Google Scholar
• Schneider A, Zhang Y, Guan Y, Davis LS, Breyer MD. Differential, inducible gene targeting in renal epithelia, vascular endothelium, and viscera of Mx1Cre mice. Am. J. Physiol. Renal Physiol.284(2), F411–F417 (2003).
   Google Scholar
• Metzger D, Clifford J, Chiba H, Chambon P. Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc. Natl Acad. Sci. USA92(15), 6991–6995 (1995).
   PubMed Web of Science ®Google Scholar
• Feil R, Brocard J, Mascrez B, LeMeur M, Metzger D, Chambon P. Ligand-activated site-specific recombination in mice. Proc. Natl Acad. Sci. USA93(20), 10887–10890 (1996).
   PubMed Web of Science ®Google Scholar
• Feil R, Wagner J, Metzger D, Chambon P. Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem. Biophys. Res. Commun.237(3), 752–757 (1997).
   PubMed Web of Science ®Google Scholar
• Kemp R, Ireland H, Clayton E, Houghton C, Howard L, Winton DJ. Elimination of background recombination: somatic induction of Cre by combined transcriptional regulation and hormone binding affinity. Nucleic Acids Res.32(11), E92 (2004).
   Google Scholar
• Thyagarajan B, Guimaraes MJ, Groth AC, Calos MP. Mammalian genomes contain active recombinase recognition sites. Gene244(1–2), 47–54 (2000).
   PubMed Web of Science ®Google Scholar
• Senecoff JF, Bruckner RC, Cox MM. The FLP recombinase of the yeast 2-micron plasmid: characterization of its recombination site. Proc. Natl Acad. Sci. USA82(21), 7270–7274 (1985).
   PubMed Web of Science ®Google Scholar
• Gossen M, Bonin AL, Bujard H. Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements. Trends Biochem. Sci.18(12), 471–475 (1993).
   PubMed Web of Science ®Google Scholar
• Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl Acad. Sci. USA89(12), 5547–5551 (1992).
   PubMed Web of Science ®Google Scholar
• Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science268(5218), 1766–1769 (1995).
   PubMed Web of Science ®Google Scholar
• Clarke AR. Wnt signalling in the mouse intestine. Oncogene25(57), 7512–7521 (2006).
   PubMed Web of Science ®Google Scholar
• Clevers H. Wnt/β-catenin signaling in development and disease. Cell127(3), 469–480 (2006).
   PubMed Web of Science ®Google Scholar
• Moser AR, Shoemaker AR, Connelly CS et al. Homozygosity for the Min allele of Apc results in disruption of mouse development prior to gastrulation. Dev. Dyn.203(4), 422–433 (1995).
   PubMed Web of Science ®Google Scholar
• Sansom OJ, Reed KR, Hayes AJ et al. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev.18(12), 1385–1390 (2004).
   PubMed Web of Science ®Google Scholar
• Andreu P, Colnot S, Godard C et al. Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine. Development132(6), 1443–1451 (2005).
   PubMed Web of Science ®Google Scholar
• Preston SL, Wong WM, Chan AO et al. Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission. Cancer Res.63(13), 3819–3825 (2003).
   PubMed Web of Science ®Google Scholar
• Shibata H, Toyama K, Shioya H et al. Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science278(5335), 120–123 (1997).
   PubMed Web of Science ®Google Scholar
• Colnot S, Niwa-Kawakita M, Hamard G et al. Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers. Lab. Invest.84(12), 1619–1630 (2004).
   PubMed Web of Science ®Google Scholar
• Lilien J, Balsamo J. The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of β-catenin. Curr. Opin. Cell Biol.17(5), 459–465 (2005).
   PubMed Web of Science ®Google Scholar
• Wong NA, Pignatelli M. β-catenin-a linchpin in colorectal carcinogenesis? Am. J. Pathol.160(2), 389–401 (2002).
   PubMed Web of Science ®Google Scholar
• Wong MH, Rubinfeld B, Gordon JI. Effects of forced expression of an NH2-terminal truncated β-catenin on mouse intestinal epithelial homeostasis. J. Cell Biol.141(3), 765–777 (1998).
   PubMed Web of Science ®Google Scholar
• Romagnolo B, Berrebi D, Saadi-Keddoucci S et al. Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated β-catenin. Cancer Res.59(16), 3875–3879 (1999).
   PubMed Web of Science ®Google Scholar
• Harada N, Tamai Y, Ishikawa T et al. Intestinal polyposis in mice with a dominant stable mutation of the β-catenin gene. EMBO J.18(21), 5931–5942 (1999).
   PubMed Web of Science ®Google Scholar
• van de Wetering M, Sancho E, Verweij C et al. The β–catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell111(2), 241–250 (2002).
   PubMed Web of Science ®Google Scholar
• Bettess MD, Dubois N, Murphy MJ et al. c-Myc is required for the formation of intestinal crypts but dispensable for homeostasis of the adult intestinal epithelium. Mol. Cell Biol.25(17), 7868–7878 (2005).
   PubMed Web of Science ®Google Scholar
• Muncan V, Sansom OJ, Tertoolen L et al. Rapid loss of intestinal crypts upon conditional deletion of the Wnt/Tcf–4 target gene c-Myc. Mol. Cell Biol.26(22), 8418–8426 (2006).
   PubMed Web of Science ®Google Scholar
• Ignatenko NA, Holubec H, Besselsen DG et al. Role of c–Myc in intestinal tumorigenesis of the ApcMin/+ mouse(1). Cancer Biol. Ther.5(12) 1658–1664 (2006).
   PubMed Web of Science ®Google Scholar
• Sansom OJ, Meniel VS, Muncan V et al. Myc deletion rescues Apc deficiency in the small intestine. Nature DOI:10.1038/nature05674 (2007) (Epub ahead of print).
   PubMedGoogle Scholar
• Saito S, Liu B, Yokoyama K. Animal embryonic stem (ES) cells: self-renewal, pluripotency, transgenesis and nuclear transfer. Hum. Cell17(3), 107–115 (2004).
   PubMedGoogle Scholar
• Burgess S, Reim G, Chen W, Hopkins N, Brand M. The zebrafish spiel-ohne-grenzen (spg) gene encodes the POU domain protein Pou2 related to mammalian Oct4 and is essential for formation of the midbrain and hindbrain, and for pre-gastrula morphogenesis. Development129(4), 905–916 (2002).
   PubMed Web of Science ®Google Scholar
• Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med.10(1), 55–63 (2004).
   PubMed Web of Science ®Google Scholar
• Hochedlinger K, Yamada Y, Beard C, Jaenisch R. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell121(3), 465–477 (2005).
   PubMed Web of Science ®Google Scholar
• Wilson A, Radtke F. Multiple functions of Notch signaling in self-renewing organs and cancer. FEBS Lett.580(12), 2860–2868 (2006).
   PubMed Web of Science ®Google Scholar
• van Es JH, van Gijn ME, Riccio O et al. Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature435(7044), 959–963 (2005).
   PubMed Web of Science ®Google Scholar
• Fre S, Huyghe M, Mourikis P, Robine S, Louvard D, Artavanis-Tsakonas S. Notch signals control the fate of immature progenitor cells in the intestine. Nature435(7044), 964–968 (2005).
   PubMed Web of Science ®Google Scholar
• Zecchini V, Domaschenz R, Winton D, Jones P. Notch signaling regulates the differentiation of post-mitotic intestinal epithelial cells. Genes Dev.19(14), 1686–1691 (2005).
   PubMed Web of Science ®Google Scholar
• Sancho E, Batlle E, Clevers H. Signaling pathways in intestinal development and cancer. Annu. Rev. Cell Dev. Biol.20, 695–723 (2004).
   PubMed Web of Science ®Google Scholar
• Hahm KB, Lee KM, Kim YB et al. Conditional loss of TGF-β signalling leads to increased susceptibility to gastrointestinal carcinogenesis in mice. Aliment. Pharmacol. Ther.16(Suppl 2), 115–127 (2002).
   PubMed Web of Science ®Google Scholar
• Ishizuya-Oka A. Epithelial-connective tissue cross-talk is essential for regeneration of intestinal epithelium. J. Nippon Med. Sch.72(1), 13–18 (2005).
   PubMedGoogle Scholar
• Chow E, Macrae F. A review of juvenile polyposis syndrome. J. Gastroenterol. Hepatol.20(11), 1634–1640 (2005).
   PubMed Web of Science ®Google Scholar
• He XC, Zhang J, Tong WG et al. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt–β–catenin signaling. Nat. Gen.36(10), 1117–1121 (2004).
   PubMed Web of Science ®Google Scholar
• Bjerknes M, Cheng H. Re-examination of P-PTEN staining patterns in the intestinal crypt. Nat. Genet.37(10), 1016–1017; author reply 1017–1018 (2005).
   PubMed Web of Science ®Google Scholar
• He XC, Li L. Reply to Re-examination of P-PTEN staining patterns in the intestinal crypt. Nat. Genet.37, 1017–1018 (2005).
   Web of Science ®Google Scholar
• Haramis AP, Begthel H, van den Born M et al. De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science303(5664), 1684–1686 (2004).
   PubMed Web of Science ®Google Scholar
• Batts LE, Polk DB, Dubois RN, Kulessa H. BMP signaling is required for intestinal growth and morphogenesis. Dev. Dyn.235(6), 1563–1570 (2006).
   PubMed Web of Science ®Google Scholar
• Kim BG, Li C, Qiao W et al. Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature441(7096), 1015–1019 (2006).
   PubMed Web of Science ®Google Scholar
• He XC, Yin T, Grindley JC et al. PTEN-deficient intestinal stem cells initiate intestinal polyposis. Nat. Genet.39(2), 189–198 (2007).
   PubMed Web of Science ®Google Scholar
• Malumbres M, Barbacid M. RAS oncogenes: the first 30 years. Nat. Rev. Cancer3(6), 459–465 (2003).
   PubMed Web of Science ®Google Scholar
• Janssen KP, El-Marjou F, Pinto D et al. Targeted expression of oncogenic K-Ras in intestinal epithelium causes spontaneous tumorigenesis in mice. Gastroenterology123(2), 492–504 (2002).
   PubMed Web of Science ®Google Scholar
• Tuveson DA, Shaw AT, Willis NA et al. Endogenous oncogenic K-Ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell5(4), 375–387 (2004).
   PubMed Web of Science ®Google Scholar
• Sansom OJ, Meniel V, Wilkins JA et al. Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-Ras oncogene in vivo. Proc. Natl Acad. Sci. USA103(38), 14122–14127 (2006).
   PubMed Web of Science ®Google Scholar